CLINICAL ROLE -
SGLT-2 Inhibitors Associated with Reduced Hyperkalemia in Patients With Heart Failure
SGLT-2 inhibitors reduce cardiovascular deaths, heart failure hospitalizations, hyperkalemia, and decline of renal function in patients with HFrEF.
Read More